Multiple Myeloma Treatment Market Analysis by Treatment, Diagnosis and Research Advancements
Multiple
Myeloma Treatment Market Highlights:
Multiple myeloma is a type of cancer formed
due to malignant plasma cells. Plasma cells are found in the bone marrow and
are an important part of the immune system. Multiple myeloma causes cancer
cells to accumulate in the bone marrow, where they attack the healthy blood
cells.
Multiple
Myeloma Treatment Market to grow 11.0% CAGR during the Forecast Period 2018 to
2023
These malignant plasma cells then produce
abnormal proteins which may cause a tumor, damage the kidneys, and impair
immune system function. The global multiple myeloma market is mainly driven by
an increase in aging population, increase in healthcare expenditure, and
increased penetration of novel cancer drugs, whereas key players in the market
are engaged in the innovation of new cancer products, trends of combination
therapies, and the chance of new players.
Intended
Audience
- Manufacturers
and Suppliers
- Hospitals
and clinics
- Laboratories
and Associations
- Research
institutes
Get
Sample Research Report at https://www.marketresearchfuture.com/sample_request/6818
Key Players:
Some of the key players in the global multiple myeloma treatment market
are Celgene Corporation,
Janssen Biotech, Inc., Bristol-Myers Squibb Company, Novartis AG,
Millennium Pharmaceuticals, Amgen, Inc., Genzyme Corporation, Juno
Therapeutics, Johnson & Johnson, F. Hoffmann-La Roche Ltd., GlaxoSmithKline
plc, AbbVie Inc., Novartis AG, Innate Pharma SA, and Celldex Therapeutics,
Inc., Onyx Pharmaceuticals, Pfizer, Takeda Pharmaceuticals.
Pune, India, July 2018/MRFR
Press Release/- Market Research Future has published a half-cooked research
report on the global multiple myeloma treatment market
Global Multiple Myeloma
Treatment Market, by Treatment
- Chemotherapy
- Bendamustine
(Treanda)
- Cyclophosphamide
(Cytoxan)
- Doxorubicin
(Adriamycin)
- Etoposide
- Liposomal
doxorubicin (Doxil)
- Melphalan
(Alkeran, Evomela)
- Vincristine
(Oncovin)
- Corticosteroids
- Interferon
- Stem Cell Transplant
- Radiation Therapy
Global Multiple Myeloma
Treatment Market, by End User
- Hospitals
- Clinics
- Independent
pharmacies
- Others
Browse Complete Premium
Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/multiple-myeloma-treatment-market-6818
Regional Analysis:
The market in the Americas is expected to dominate the global multiple
myeloma treatment market during the forecast period owing to the increase in
the prevalence of blood cancer, the rise in geriatric population, unhealthy
lifestyle, growth in demand of biologic therapies, and the emergence of
nanomedicine drive the market.
The European market is expected to be the second-largest due to
government funding, and support of the healthcare sector coupled with the
growing incidence of elderly patients, growing prevalence of myeloma disease
along with the surging elderly population is the prime factor expected to drive
the growth significantly in this region.
Moreover, the market in Asia-Pacific is anticipated to be the
fastest-growing during the assessment period owing to increase in aging
population, rising obese population, increase in healthcare expenditure and
increased penetration of novel cancer drugs. The market in the Middle East
& Africa is likely to account for the smallest share of this market. The market
growth in this region can be attributed to
Inquire
for Discount at https://www.marketresearchfuture.com/check-discount/6818
About Market Research
Future: MRFR team have supreme
objective to provide the optimum quality market research and intelligence
services to our clients. Our market research studies by products, services,
technologies, applications, end users, and market players for global, regional,
and country level market segments, enable our clients to see more, know more,
and do more, which help to answer all their most important questions.
In order to stay
updated with technology and work process of the industry, MRFR often plans
& conducts meet with the industry experts and industrial visits for its
research analyst members.
Contact:
Office No.
528, Amanora Chambers
Magarpatta Road,
Hadapsar, Pune
+1 646 845 9312
Comments
Post a Comment